131 related articles for article (PubMed ID: 7888674)
21. Ocular inflammation stimulated by the immunomodulator AS101 [ammonium trichloro(dioxyethelene-O-O') tellurate].
Dastgheib K; Hikita N; Sredni B; Albeck M; Sredni D; Nussenblatt RB; Chan CC
Curr Eye Res; 1994 Aug; 13(8):603-10. PubMed ID: 7956313
[TBL] [Abstract][Full Text] [Related]
22. Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin.
Sredni B; Kalechman Y; Albeck M; Gross O; Aurbach D; Sharon P; Sehgal SN; Gurwith MJ; Michlin H
Immunology; 1990 Aug; 70(4):473-7. PubMed ID: 2118479
[TBL] [Abstract][Full Text] [Related]
23. Novel involvement of the immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase Fer.
Hayun R; Shpungin S; Malovani H; Albeck M; Okun E; Nir U; Sredni B
Ann N Y Acad Sci; 2007 Jan; 1095():240-50. PubMed ID: 17404037
[TBL] [Abstract][Full Text] [Related]
24. Synergism between AS101 and PMA in lymphokine production.
Sredni B; Kalechman Y; Shalit F; Albeck M
Immunology; 1990 Jan; 69(1):110-6. PubMed ID: 2107143
[TBL] [Abstract][Full Text] [Related]
25. Radioprotective effects of ginsan, an immunomodulator.
Song JY; Han SK; Bae KG; Lim DS; Son SJ; Jung IS; Yi SY; Yun YS
Radiat Res; 2003 Jun; 159(6):768-74. PubMed ID: 12751959
[TBL] [Abstract][Full Text] [Related]
26. The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice.
Rosenblatt-Bin H; Kalechman Y; Vonsover A; Xu RH; Da JP; Shalit F; Huberman M; Klein A; Strassmann G; Albeck M; Sredni B
Cell Immunol; 1998 Feb; 184(1):12-25. PubMed ID: 9626331
[TBL] [Abstract][Full Text] [Related]
27. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression.
Sredni B; Gal R; Cohen IJ; Dazard JE; Givol D; Gafter U; Motro B; Eliyahu S; Albeck M; Lander HM; Kalechman Y
FASEB J; 2004 Feb; 18(2):400-2. PubMed ID: 14656992
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation by ammonium trichloro(dioxoethylene-0,0') tellurate (AS101) of Fas/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101.
Kalechman Y; Strassmann G; Albeck M; Sredni B
J Immunol; 1998 Oct; 161(7):3536-42. PubMed ID: 9759874
[TBL] [Abstract][Full Text] [Related]
29. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models.
Sredni B; Xu RH; Albeck M; Gafter U; Gal R; Shani A; Tichler T; Shapira J; Bruderman I; Catane R; Kaufman B; Whisnant JK; Mettinger KL; Kalechman Y
Int J Cancer; 1996 Jan; 65(1):97-103. PubMed ID: 8543404
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.
Kalechman Y; Gafter U; Weinstein T; Chagnac A; Freidkin I; Tobar A; Albeck M; Sredni B
J Biol Chem; 2004 Jun; 279(23):24724-32. PubMed ID: 15001575
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide.
Sredni B; Albeck M; Tichler T; Shani A; Shapira J; Bruderman I; Catane R; Kaufman B; Kalechman Y
J Clin Oncol; 1995 Sep; 13(9):2342-53. PubMed ID: 7666093
[TBL] [Abstract][Full Text] [Related]
32. The cytoprotective effect of the immunomodulator AS101 against hydrochloride induced gastric lesions.
Xu RH; Kalechman Y; Albeck M; Sredni B
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):4-20. PubMed ID: 7735728
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of B16 melanoma metastasis by the immunomodulator AS101.
Xu R; Kalechman Y; Albeck M; Kung H; Sredni B
Int J Oncol; 1996 Aug; 9(2):319-25. PubMed ID: 21541518
[TBL] [Abstract][Full Text] [Related]
34. The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody.
Blank M; Sredni B; Albeck M; Mozes E; Shoenfeld Y
Clin Exp Immunol; 1990 Mar; 79(3):443-7. PubMed ID: 2317948
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo activity of AS101 against West Nile virus (WNV).
Indenbaum V; Bin H; Makarovsky D; Weil M; Shulman LM; Albeck M; Sredni B; Mendelson E
Virus Res; 2012 Jun; 166(1-2):68-76. PubMed ID: 22445690
[TBL] [Abstract][Full Text] [Related]
36. Antibabesial effect of the immunomodulator AS101 in mice: role of increased production of nitric oxide.
Rosenblatt-Bin H; Klein A; Sredni B
Parasite Immunol; 1996 Jun; 18(6):297-306. PubMed ID: 9229382
[TBL] [Abstract][Full Text] [Related]
37. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
Inoue H; Koezuka Y; Nishi N; Osawa M; Motoki K; Kobayashi E; Kabaya K; Obuchi M; Fukushima H; Mori KJ
Exp Hematol; 1997 Aug; 25(9):935-44. PubMed ID: 9257806
[TBL] [Abstract][Full Text] [Related]
38. Immunologic effects of AS101 in the treatment of cancer patients.
Shani A; Tichler T; Catane R; Gurwith M; Rozenszajn LA; Gezin A; Levi E; Schlesinger M; Kalechman Y; Michlin H
Nat Immun Cell Growth Regul; 1990; 9(3):182-90. PubMed ID: 2370878
[TBL] [Abstract][Full Text] [Related]
39. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway.
Hayun M; Naor Y; Weil M; Albeck M; Peled A; Don J; Haran-Ghera N; Sredni B
Biochem Pharmacol; 2006 Nov; 72(11):1423-31. PubMed ID: 16889755
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic cytokines enhance survival of SCID mice undergoing high-dose irradiation.
Wu DD; Bosch B; Keating A
Exp Hematol; 1994 Feb; 22(2):202-7. PubMed ID: 7507860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
